General DetailsProfileCPH PublicationsExternal Publications
Dr Harry Sumnall

Substance Use

Reader

e-mail Tel No: 0151 231 8096

I am Reader in Substance Use. My work covers all aspects of substance use, but I have a particular interest in young people's health issues. Recent work has developed and delivered a primary and secondary research programme examining the evidence base for drug misuse prevention and the mechanisms for implementing evidence based practice. Based on this work, we recommend how policy and practice can be developed in order to best prevent drug misuse across the United Kingdom. I also have research interests in psychopharmacology, and addictive behaviours, with a focus upon causes, consequences, and experiences of drug use. Alongside collaborating colleagues in the UK, USA, and EU, I am interested in the psychopharmacology of entactogens and hallucinogens; in particular MDMA (ecstasy) and psilocybin.

I am interested in supervising PG students wishing to study most topics in illegal drug use; drug prevention; and I'm particularly interested in supervising research employing quantitative methods.

I'm a reviewer for the journals The Lancet; Psychopharmacology; Addiction; Journal of Psychopharmacology; Addictive Behaviors; Drug and Alcohol Review; Drug and Alcohol Dependence; International Journal of Drug Policy; Anxiety and Depression; Journal of Urban Health; BMC Public Health.

I'm an academic referee for the Home Office RDS; NIHR PHR Programme.

I'm a grant referee for the MRC, ESRC, British Academy, British Council, BIG Lottery Fund

 

 

Grants (>£15,000)

    1. Co-lead - European Family Empowerment: Improving family skills to prevent alcohol and drug related problems. January 2010 - January 2013; €396,000. Funding Body: EU

    2. Co-lead - Fieldwork to inform the development of NICE guidance on the prevention of alcohol use disorders. September - November 2010; £30,000. funding body: NICE
    3. Lead - Assessment of R&D Culture in NHS Wirral. December 2008 - May 2009; £20,000. Funding Body: Wirral NHS
    4. Co-lead - Systematic Reviews of the effectiveness of PSHE in schools. March - November 2009; £100,000. Funding Body: NICE
    5. Lead - Transmission of young people's drinking culture via media. March 2008 - September 2009; £100,000. Funding Body: JRF
    6. Lead - Health Needs Assessment HMP Liverpool, Forest Bank, Kennett; total: £40,000
    7. Lead - Evaluation of Rolling Group Model of smoking cessation. December 2008 - March 2009; £15,000
    8. Lead - Mapping of behavioural interventions in Cheshire and Merseyside. November 2008 - March 2009; £20,000. Funding Body: ChaMPs
    9. Co-lead – review of effectiveness and cost effectiveness of optimum provision of needle exchanges for injecting drug users. January – September 2008; £127,500 . Funding Body: NICE
    10. Lead – EU Standards in Drug prevention. 2007 – 2009; €284,507. Funding Body: EU Public Health Executive Agency
    11. Lead – Perceptions of new smoking cessation interventions by young people. September – December 2007; £29,683. Funding body: NICE
    12. Collaborator – Inhibitory control and cue salience in alcohol abuse. June 2007 – June 2009; £283,104. Funding body: Medical Research Council
    13. Lead – Reference methodological package on the EMCDDA General Population Survey Indicator. February 2007 – July 2008; €10,950. Funding Body: EMCDDA, Lisbon
    14. Lead – Evaluation of projects working in High Focus Areas. January – December 2007; £98,226. Funding Body: Department of Health
    15. Lead – A pilot intervention providing individually tailored feedback on alcohol consumption in University students. January – December 2007; £4915. Funding Body: AERC
    16. Lead – Evaluation of Families First. November 2006 – December 2008; £83,312. Funding Body: Department of Health
    17. Co-lead – Substance misuse interventions – fieldwork. September – November 2006; £45,000. Funding Body: NICE
    18. Co-lead – Community based interventions for the reduction of substance misuse among vulnerable and disadvantaged young people. A rapid review. March – September 2006; £65,007. Funding Body: NICE
    19. Co-lead – Evaluation of Alcohol Brief Intervention. November 2005 – March 2006; £9836. Funding body Preston PCT
    20. Co-lead – Class A drug use in Wirral D(A)AT. April – November 2006; £28,276. Funding body, Wirral D(A)AT
    21. Co-lead – Class A drug use in Knowsley D(A)AT. April – September 2006; £14,000. Funding body, Knowsley D(A)AT
    22. Co-lead – Young People and Substance Misuse: Characteristics, Needs and Perception of Treatment Services of Drug Users Aged 18 to 25 in Liverpool. April – September 2006; £20,994.18. Funding body, Liverpool D(A)AT
    23. Lead – Risk perception and risk taking behaviours in non-treatment seeking drug users. June 2006 – March 2007; £7006. Funding Body, British Academy (UK)
    24. Co-lead - Work Programme on Drug Prevention Evidence Review and Dissemination. October 2005 - October 2006; £101,000. Funding Body, Department of Health (UK)
    25. Co-lead - Scoping exercise on Drugs Prevention in the Community and Server Focussed intoxication management strategies. September 2005 - November 2005; £40,000. Funding body, NICE (UK)
    26. Co-lead– Health Development Agency (currently National Institute of Health and Clinical Excellence) Collaborating Centre (Drug Prevention). 1st April 2004 – 31st March 2006; ~ £100,000/year. Funding Body, NICE (UK)
    27. Co-lead - Assessment, integration and deliver of evidence from government sponsored research on the prevention of drug misuse in a manner which maximises the implementation of evidence based practice. September 2004 – September 2006; £160,000/year. Funding Body, Department of Health (UK)
    28. Lead - Assistance to European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the analysis of drug use profiles from EMCDDA Databank on surveys on drug use’. February – October 2004; €16,000. Funding Body, EMCDDA (Portugal)